Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory of Diagnosis and Therapy of Lysosomal Disorders, |
RCV001375873 | SCV005089004 | pathogenic | Mucopolysaccharidosis, MPS-II | 2024-06-07 | criteria provided, single submitter | literature only | Null variant (PVS1_VeryStrong), Absent from controls (or at low frequency) in gnomAD database (PM2_Moderate), Patient’s phenotype or family history highly specific for the disease (PP4_Moderate) |
Pediatrics, |
RCV001375873 | SCV001572774 | likely pathogenic | Mucopolysaccharidosis, MPS-II | 2014-11-01 | no assertion criteria provided | research | The variant c.356_356delT (p.I119Tfs*11) was found to be a novel small frame-shift deletion, where a single base deletion leads to frameshift change in the ORF of the translated peptide leading to the substitution of aliphatic nonpolar neutral amino acid Isoleucine at 119 position by a hydroxyl-containing polar neutral amino acid Threonine. This leads to change in peptide sequence and formation of a stop codon change at 11 amino acid downstream of the mutation. In silico analysis by the web tool Mutation Taster characterise it as a "Disease causing" pathogenic variant. It was detected in one patient with attenuated phenotype from Uttar Pradesh,India. |